SI9300595B - Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji - Google Patents
Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji Download PDFInfo
- Publication number
- SI9300595B SI9300595B SI9300595A SI9300595A SI9300595B SI 9300595 B SI9300595 B SI 9300595B SI 9300595 A SI9300595 A SI 9300595A SI 9300595 A SI9300595 A SI 9300595A SI 9300595 B SI9300595 B SI 9300595B
- Authority
- SI
- Slovenia
- Prior art keywords
- xaa
- disorders
- amino acid
- peptides
- zaa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Claims (2)
1 Patentna zahtevka 1. Uporaba biološko visoko aktivnih peptidov, ki obstoje iz 8 do 15 ostankov amino kislin in jih predstavlja splošna formula: Xaa Zaa Pro Pro Pro Xaa Yaa Pro Ala Asp Zaa Ala Xaa Xaa Xaa 15 10 15 kjer Xaa pomeni ostanek nevtralne alifatske amino kisline, kot Ala, bAla, Leu, Ile, Gly, Val, Nle, Nva, Yaa pomeni ostanek bazične amino kisline, kot Lys, Arg, Om, His, Zaa pomeni ostanek kisle amino kisline, kot Glu, Asp, Aad ali Apm; pri čemer je lahko vsaj eden od ostankov Xaa ali Zaa izpuščen, in/ali kateregakoli od peptidov s Seq.Id.No:l do 11 za pripravo farmacevtskega sestavka za zdravljenje motenj in poškodb jeter, ledvic in trebušne slinovke, atrofije testisov in gibljivosti spermijev, motenj plodnosti, za izboljšanje komercialne reje, za zdravljenje rikecijskih bolezni, tireoparatireoidoktomije, sladkorne bolezni, motenj nadledvične žleze, spremembe hematopoetske sestave, motenj koagulacije, motenj krvavenja, post-kastracijskih/menopavvznih motenj, ishemičnih in toksičnih poškodb, psihiatričnih motenj, hipertenzije, motenj telesne temperature, bolečine ali tumoija.
2. Uporaba po zahtevku 1, označena s tem, da peptid cikliziramo s pomočjo amidne vezi med prvim in zadnjim ostankom amino kisline.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR921283 | 1992-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
SI9300595A SI9300595A (en) | 1994-09-30 |
SI9300595B true SI9300595B (sl) | 2003-04-30 |
Family
ID=10945833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9300595A SI9300595B (sl) | 1992-11-16 | 1993-11-16 | Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0624164B1 (sl) |
JP (1) | JP2812803B2 (sl) |
AT (1) | ATE163131T1 (sl) |
AU (1) | AU5624994A (sl) |
BG (1) | BG61697B1 (sl) |
CA (1) | CA2127553C (sl) |
CZ (1) | CZ285155B6 (sl) |
DE (1) | DE69316974T2 (sl) |
ES (1) | ES2114170T3 (sl) |
GR (1) | GR3026478T3 (sl) |
HU (3) | HUT66303A (sl) |
PL (1) | PL304666A1 (sl) |
RO (1) | RO115733B1 (sl) |
RU (1) | RU2116311C1 (sl) |
SI (1) | SI9300595B (sl) |
SK (1) | SK279227B6 (sl) |
WO (1) | WO1994011394A2 (sl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199902866T2 (xx) | 1997-05-23 | 2000-02-21 | Sikiric Predrag | Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler. |
SI24318A (sl) * | 2013-03-13 | 2014-09-30 | Diagen D.O.O. | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU176089A (sh) * | 1989-09-12 | 1992-09-07 | Sikirić, Predrag | Postupak za pripremu supstancije bpc i supstancija bpc |
ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
-
1993
- 1993-11-16 CZ CZ941622A patent/CZ285155B6/cs not_active IP Right Cessation
- 1993-11-16 SI SI9300595A patent/SI9300595B/sl not_active IP Right Cessation
- 1993-11-16 JP JP6511727A patent/JP2812803B2/ja not_active Expired - Fee Related
- 1993-11-16 PL PL93304666A patent/PL304666A1/xx unknown
- 1993-11-16 RU RU94037232A patent/RU2116311C1/ru not_active IP Right Cessation
- 1993-11-16 AT AT94901809T patent/ATE163131T1/de active
- 1993-11-16 ES ES94901809T patent/ES2114170T3/es not_active Expired - Lifetime
- 1993-11-16 AU AU56249/94A patent/AU5624994A/en not_active Abandoned
- 1993-11-16 WO PCT/EP1993/003217 patent/WO1994011394A2/en active IP Right Grant
- 1993-11-16 HU HU9303247A patent/HUT66303A/hu unknown
- 1993-11-16 DE DE69316974T patent/DE69316974T2/de not_active Expired - Lifetime
- 1993-11-16 HU HU9401952A patent/HUT67982A/hu unknown
- 1993-11-16 EP EP94901809A patent/EP0624164B1/en not_active Expired - Lifetime
- 1993-11-16 RO RO94-01091A patent/RO115733B1/ro unknown
- 1993-11-16 CA CA002127553A patent/CA2127553C/en not_active Expired - Fee Related
- 1993-11-16 SK SK857-94A patent/SK279227B6/sk not_active IP Right Cessation
-
1994
- 1994-07-15 BG BG98907A patent/BG61697B1/bg unknown
-
1995
- 1995-06-21 HU HU95P/P00304P patent/HU211260A9/hu unknown
-
1998
- 1998-03-27 GR GR980400664T patent/GR3026478T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT67982A (en) | 1995-05-29 |
SK279227B6 (sk) | 1998-08-05 |
ATE163131T1 (de) | 1998-02-15 |
SK85794A3 (en) | 1995-01-12 |
DE69316974D1 (de) | 1998-03-19 |
EP0624164B1 (en) | 1998-02-11 |
CZ162294A3 (en) | 1995-02-15 |
CZ285155B6 (cs) | 1999-05-12 |
CA2127553C (en) | 2003-01-28 |
HUT66303A (en) | 1994-11-28 |
HU211260A9 (en) | 1995-11-28 |
DE69316974T2 (de) | 1998-07-16 |
WO1994011394A3 (en) | 1994-09-15 |
RO115733B1 (ro) | 2000-05-30 |
SI9300595A (en) | 1994-09-30 |
AU5624994A (en) | 1994-06-08 |
HU9401952D0 (en) | 1994-09-28 |
EP0624164A1 (en) | 1994-11-17 |
JP2812803B2 (ja) | 1998-10-22 |
JPH07507568A (ja) | 1995-08-24 |
CA2127553A1 (en) | 1994-05-26 |
RU94037232A (ru) | 1996-06-20 |
WO1994011394A2 (en) | 1994-05-26 |
RU2116311C1 (ru) | 1998-07-27 |
HU9303247D0 (en) | 1994-03-28 |
GR3026478T3 (en) | 1998-06-30 |
PL304666A1 (en) | 1995-01-09 |
ES2114170T3 (es) | 1998-05-16 |
BG61697B1 (bg) | 1998-03-31 |
BG98907A (bg) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0532696A (ja) | 副甲状腺ホルモン誘導体 | |
ES2001274A6 (es) | Un metodo para preparar peptidos que tienen influencia sobre la funcion de la glandula pituitaria en seres humanos y otros animales | |
IL69897A (en) | Human pancreatic grf analogs,compositions comprising them and use thereof | |
CA2027936A1 (en) | Cyclic anti-aggregatory peptides | |
ES2055792T3 (es) | Compuestos analogos ciclicos a grf. | |
CA2453112A1 (en) | New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls | |
AU641215B2 (en) | Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin | |
US6743895B1 (en) | Bone stimulating factor | |
KR0162893B1 (ko) | 항응고성 펩타이드 및 이를 함유하는 조성물 | |
JPH03120297A (ja) | 抗凝固ペプチド | |
US5786335A (en) | Sulfhydryl containing peptides for treating vascular disease | |
SI9300595B (sl) | Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji | |
Kiyama et al. | Synthesis of porcine neuropeptide Y (NPY) in solution | |
HU211346A9 (en) | Stabilized potent grf analogs | |
CA2063260A1 (en) | Vasodilatory and immune suppressant peptides | |
HU187503B (en) | Process for preparing gonadoliberine derivatives containing beta-aspartyl group | |
JP2003501109A5 (sl) | ||
WO2000075185A1 (en) | Bone stimulating factor | |
JPH05500962A (ja) | 硫酸エステル基を有するヘキサペプチド |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF | Valid on the event date | ||
KO00 | Lapse of patent |
Effective date: 20120627 |